Can natalizumab cause thrombocytopenia, including immune thrombocytopenic purpura?

Thrombocytopenia, including immune thrombocytopenic purpura, has been reported with Tysabri (natalizumab), and discontinuation should be considered if thrombocytopenia is identified.